Investigator seeks to determine wether integrating an addiction team into a liver transplantation unit improves the prognosis of patients with alcohol-related liver disease requiring liver transplantation. Our hypothesis is that patients managed by an addiction team before and after liver transplantation have less frequent alcohol relapses, thus decreasing the risk of cardiovascular complications, de novo cancer, recurrence of alcohol-related cirrhosis, and consequently increasing their overall survival.

In this observational, retrospective and multicentre study, investigator seek to determine the effect of integrating an addiction team into liver transplantation unit on prognosis of patients with alcohol-related liver disease requiring liver transplantation. Investigatore plan to compare patients in 2 groups, depending on whether they have received or not specific addiction care before and after transplantation. This study was conducted over a period of 15 years in three French liver transplant units.

Inclusion criteria:

• adult patients
• who received a liver transplant between January 2000 and December 2015 for alcohol-related liver disease as a primary or secondary indication (hepatocellular carcinoma)
• who survived for more than 6 months after their liver transplant.

Exclusion criteria:

• association of other causes of hepatopathy: viral hepatitis B or C, hereditary hemochromatosis.
• death before discharge from hospital after liver transplantation.
• patient unwilling to participate to the study

Adult patients with alcohol-related liver disease, possibly complicated by hepatocellular carcinoma, that required liver transplantation in participating centers from January 2000 to December 2015.

• Saint Eloi University Hospital, University of Montpellier
• Edouard Herriot University Hospital, Hospices Civils de Lyon
• Rangueil University Hospital, University of Toulouse

NC